[1] 汪培涛,曹家俊,魏学忠,等.骨质疏松性椎体压缩骨折三种治疗方式的临床评价[J].中国骨与关节杂志,2020,9(1):57-64.
[2] 毕松超,陈涛,杨建东,等.骨质疏松椎体压缩性骨折行椎体成形术术后再骨折的危险因素分析[J].骨科,2017,8(6):423-427.
[3] 王芳芳,刘红正,王拴池,等.椎体强化术后再发椎体骨折的临床特点和危险因素[J].世界最新医学信息文摘,2018,18(50):57+60.
[4] 陈建常,王鑫,马在松,等.骨质疏松患者PVP/PKP术后新发椎体压缩性骨折相关危险因素[J].中国矫形外科杂志,2015,23(10):902-907.
[5] NING L, WAN S, LIU C, et al. New Levels of Vertebral Compression Fractures after Percutaneous Kyphoplasty: Retrospective Analysis of Styles and Risk Factors. Pain Physician. 2015;18(6):565-572.
[6] KENJI T, MIKIO K, HIDEKI M, et al. Risk factors of adjacent vertebral collapse after percutaneous vertebroplasty for osteoporotic vertebral fracture in postmenopausal women. BMC Musculoskelet Disord. 2016;17:12.
[7] MARTINEZ‐FERRER A, BLASCO J, CARRASCO JL, et al. Risk factors for the development of vertebral fractures after percutaneous vertebroplasty. J Bone Miner Res. 2013;28(8):1821-1829.
[8] 宁磊,万双林,杨明,等.经皮椎体后凸成形术后非骨折椎体骨折的原因分析[J].中华骨科杂志,2015,35(10):990-996.
[9] 蒙锡波,张卓林,邓亚寿.经皮椎体成形术结合正规抗骨质疏松治疗女性绝经期胸腰椎骨质疏松性骨折的疗效及对骨密度的影响[J].中国医学创新, 2020,17(18):51-55.
[10] LIN CC, CHEN IH, YU TC, et al. New symptomatic compression fracture after percutaneous vertebroplasty at the thoracolumbar junction. AJNR Am J Neuroradiol. 2007;28(6):1042-1045.
[11] 李慧林,杜艳萍,洪维,等.绝经后高龄妇女身体成分、骨密度的特征及其相关性[J].中华妇产科杂志,2018,53(4):270-272.
[12] CHEN C, FAN P, XIE X, et al. Risk Factors for Cement Leakage and Adjacent Vertebral Fractures in Kyphoplasty for Osteoporotic Vertebral Fractures. Clin Spine Surg. 2020;33(6):E251-E255.
[13] LU K, LIANG CL, HSIEH CH, et al. Risk Factors of Subsequent Vertebral Compression Fractures After Vertebroplasty. Pain Medicine. 2012;13(3): 376-382.
[14] 李勃,刘凯,范红,等.补肾健骨汤联合西药治疗老年骨质疏松性胸腰椎压缩性骨折临床研究[J].陕西中医,2018,39(5):625-627.
[15] 邢帅,杨勇,王永刚,等.脊柱骨盆矢状面平衡对骨质疏松性椎体压缩性骨折经皮椎体后凸成形术后继发骨折的影响[J].中华创伤骨科杂志, 2018,20(6):487-491.
[16] COSMAN F, BEUR SJD, LEBOFF MS, et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359-2381.
[17] ADAMI G, SAAG KG. Glucocorticoid-induced osteoporosis update. Curr Opin Rheumatol. 2019;31(4):388-393.
[18] ISLAM S, LIU Q, CHINES A, et al. Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005. Menopause. 2009;16(1):77-83.
[19] 侯敏,唐茂芹,米国琳,等.精神分裂症患者骨密度影响因素研究[J].中国骨质疏松杂志,2011,17(12):1073-1076.
[20] 张保良,陈允震.骨质疏松性椎体压缩骨折住院患者的人口学特征及临床特征分析[J].中华骨科杂志,2019,39(24):1523-1535.
[21] 叶飞,张晓斌.精神分裂症患者的催乳素水平和骨质疏松[J].临床精神医学杂志,2019,29(4):283-285.
[22] BORENSZTEIN M, CAMINO WILLHUBER GO, POSADAS MARTINEZ ML, et al. Analysis of Risk Factors for New Vertebral Fracture After Percutaneous Vertebroplasty. Global Spine J. 2018;8(5):446-452.
[23] 吴永乐,陈善堂,张育专,等.老年骨质疏松患者胸腰椎压缩性骨折PKP术后 再发骨折的危险因素分析[J].医学理论与实践,2019,32(20): 3293-3295.
[24] 曾庆虎,彭成忠,吴财,等.邻近椎体新发骨折的保守与PVP治疗比较[J].中国矫形外科杂志,2019,27(22):2022-2027.
[25] 胡益文.骨质疏松患者胸腰椎压缩性骨折PKP术后再发骨折的风险因素分析[J].生物骨科材料与临床研究,2017,14(5):52-55.
[26] 韩晓东,孟纯阳.PVP术后椎体前缘高度恢复率与邻近椎体骨折的相关性研究[J].中国矫形外科杂志,2019,27(10):885-889.
[27] JOONG KH, SAEJONG P, HYUN PS, et al. Prevalence of Frailty in Patients with Osteoporotic Vertebral Compression Fracture and Its Association with Numbers of Fractures. Yonsei Med J. 2018;59(2):317-324.
[28] WANG B, GUO H, YUAN L, et al. A prospective randomized controlled study comparing the pain relief in patients with osteoporotic vertebral compression fractures with the use of vertebroplasty or facet blocking. Eur Spine J. 2016; 25(11):3486-3494.
[29] HU L, SUN H, WANG H, et al. Cement injection and postoperative vertebral fractures during vertebroplasty. J Orthop Surg Res. 2019;14(1):228.
[30] 廖旭昱,周雷杰,马维虎,等.经皮椎体后凸成形术中单侧经椎弓根穿刺角度与骨水泥分布情况的关系[J].临床骨科杂志,2012,15(3):241-244.
[31] PALMER I, NELSON J, SCHATTON W, et al. Biocompatibility of calcium phosphate bone cement with optimised mechanical properties: an in vivo study. J Mater Sci Mater Med. 2016;27(12):191.
[32] KOMEMUSHI A, TANIGAWA N, KARIYA S, et al. Percutaneous Vertebroplasty for Osteoporotic Compression Fracture: Multivariate Study of Predictors of New Vertebral Body Fracture. Cardiovasc Intervent Radiol. 2006;29(4): 580-585.
[33] GAO C, ZONG M, WANG WT, et al. Analysis of risk factors causing short-term cement leakages and long-term complications after percutaneous kyphoplasty for osteoporotic vertebral compression fractures. Acta Radiol. 2018;59(5):577-585.
[34] ALHASHASH M, SHOUSHA M, BARAKAT AS, et al. Effects of Polymethylmethacrylate Cement Viscosity and Bone Porosity on Cement Leakage and New Vertebral Fractures After Percutaneous Vertebroplasty: A Prospective Study. Global Spine J. 2019;9(7):754-760.
[35] MOROZUMI M, MATSUBARA Y, MURAMOTO A, et al. A Study of Risk Factors for Early-Onset Adjacent Vertebral Fractures After Kyphoplasty. Global Spine J. 2020;10(1):13-20.
[36] CHEVALIER Y, PAHR D, CHARLEBOIS M, et al. Cement Distribution, Volume, and Compliance in Vertebroplasty: Some Answers From an Anatomy-Based Nonlinear Finite Element Study. Spine (Phila Pa 1976). 2008;33(16): 1722-1730.
[37] LOPES PP, GARCIA MP, FERNANDES MH, et al. Acrylic formulations containing bioactive and biodegradable fillers to be used as bone cements: Properties and biocompatibility assessment. Mater Sci Eng C Mater Biol Appl. 2013;33(3):1289-1299.
[38] QINGPAN Z, FENGXUAN H, ZHIWEI H, et al. The “Magnesium Sacrifice” Strategy Enables PMMA Bone Cement Partial Biodegradability and Osseointegration Potential. Int J Mol Sci. 2018;19(6):1746.
[39] LIN WC, LEE YC, LEE CH, et al. Refractures in cemented vertebrae after percutaneous vertebroplasty: a retrospective analysis. Eur Spine J. 2008; 17(4):592-599.
[40] MIDDLETON ET, RAJARAMAN CJ, O’BRIEN DP, et al. The safety and efficacy of vertebroplasty using Cortoss cement in a newly established vertebroplasty service. Br J Neurosurg. 2008;22(2):252-256.
[41] GILULA L, PERSENAIRE M. Subsequent fractures post-vertebral augmentation: analysis of a prospective randomized trial in osteoporotic vertebral compression fractures. AJNR Am J Neuroradiol. 2013;34(1):221-227.
[42] 于爱红,冯强强,蔡韦,等.定量CT测量女性颈椎与腰椎骨密度[J].中国医学影像技术,2015,31(10):1457-1460.
[43] LEE KA, HONG SJ, LEE S, et al. Analysis of adjacent fracture after percutaneous vertebroplasty: does intradiscal cement leakage really increase the risk of adjacent vertebral fracture? Skeletal Radiol. 2011;40(12):1537-1542.
[44] 黄爱军,靳松,陈丽萍,等.腰椎椎体压缩性骨折不同固定节段的临床疗效分析[J].皖南医学院学报, 2018,37(1):28-31.
[45] JIN P, LI M, LIU X, et al. Analysis of risk factors of subsequent fractures after vertebroplasty. Eur Spine J. 2014;23(6):1339-1345.
[46] 黄江发,桑莉莉,谢雨舟,等.PVP/PKP术后非手术椎体再发骨折的相关因素分析[J].中国中医骨伤科杂志,2016(7):40-43.
[47] KIM JM, DONG AS, BYUN DH, et al. Effect of Bone Cement Volume and Stiffness on Occurrences of Adjacent Vertebral Fractures after Vertebroplasty. J Korean Neurosurg Soc. 2012;52(5):435-440.
[48] 邹向南.高粘度骨水泥椎体成形术治疗骨质疏松性椎体压缩骨折的椎体高度恢复情况及相关影响因素[J].中国脊柱脊髓杂志,2017,27(11): 991-996.
[49] 谢静颖,宁宁,陈佳丽,等.特立帕肽在行腰椎融合术骨质疏松患者中的应用[J].中国新药与临床杂志,2021,40(2):91-96.
[50] 卢春燕,陈德才.绝经后骨质疏松症的药物治疗[J].实用妇产科杂志, 2020,36(7):489-492.
[51] 劳锦锦,方略,董叶凯,等.骨质疏松性椎体骨折经皮椎体后凸成形术后再发椎体骨折的治疗[J].浙江实用医学,2017,22(5):326-328.
[52] 毕博,宋洁富,荆志振,等.多发性骨质疏松性椎体压缩骨折预防性椎体强化效果分析[J].中国药物与临床,2015,15(4):553-556.
|